BioSpace News Archive

Praxis Precision Medicines, Inc. announced that it will host a R&D Day on Monday, October 2, at 9:00 a.m. EDT, virtually and in person in New York City.

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced that it intends to offer and sell shares of its common stock and/or pre-funded warrants in an underwritten public offering.

Mirati Therapeutics, Inc.® announced several presentations to be unveiled at the European Society of Medical Oncology Congress 2023 taking place October 20 to 24, 2023 in Madrid, Spain.

Alpha Cognition Inc. is pleased to announce the submission of a New Drug Application to the U.S. Food and Drug Administration for ALPHA-1062, a proprietary, patented, delayed release oral tablet formulation in development for the treatment of mild-to-moderate Alzheimer’s Disease.

Gamida Cell Ltd., a cell therapy pioneer working to turn cells into powerful therapeutics, announced that the first patient has received a stem cell transplant with Omisirge.

Xilio Therapeutics, Inc. announced upcoming poster presentations at the Society for Immunotherapy of Cancer 38th Annual Meeting, taking place in San Diego, California from November 1-5, 2023.

MediciNova, Inc. announced the results of the nonclinical studies conducted under its contract with the BARDA, part of the Administration for Strategic Preparedness and Response in the U.S. Department of Health and Human Services, to repurpose MN-166 as a potential medical countermeasure against chlorine gas-induced lung damage such as acute respiratory distress syndrome and acute lung injury.

Ocugen, Inc. announced that Dr. Shankar Musunuri, Chairman, Chief Executive Officer and Co-Founder and Dr. Huma Qamar, MPH, CMI, Head of Clinical Development and Medical Affairs will participate in an in-person fireside chat moderated by Daniil Gataulin, PhD, Senior Biotech Research Analyst at the Chardan 7th Annual Genetic Medicines Conference being held October 2-3, 2023 in NYC.

MedMira Inc. provides an update on its progress to achieve regulatory approval in Canada and the USA for its infectious disease rapid tests.

In recent months, several media outlets have investigated an Oregon law that decriminalized possession of small amounts of controlled substances, including heroin, cocaine and methamphetamine, for some persons.